Vote Scores
Filings read through

Kiniksa Pharmaceuticals International, plc: how funds voted at the meeting of 29 May 2026

Ticker
KNSA
Meeting
Season
year to 30 June 2026
Filers reporting
303
Ballot items
6

303 filers on Form N-PX reported votes at the Kiniksa Pharmaceuticals International, plc meeting of 29 May 2026. The records fall into 6 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 71.7% of the reported votes are for. 55 filers withheld from or voted against at least one nominee.

    416 vote records from 88 filers. 9 of the 88 filers that marked the item voted against management.

    • Positions of 30 fund families
    • For 25
    • Against 5
    • Against management 5
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    531 vote records from 302 filers. 21 of the 287 filers that marked the item voted against management. 15 filers gave no management mark.

    • Positions of 36 fund families
    • For 33
    • Against 3
    • Against management 3
  3. Item 3: Audit-related items (auditor ratification)

    415 vote records from 88 filers. 0 of the 87 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 30 fund families
    • For 30
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    248 vote records from 86 filers. 3 of the 86 filers that marked the item voted against management.

    • Positions of 29 fund families
    • For 26
    • Against 1
    • Split or no vote 2
    • Against management 1
  5. Item 5: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    120 vote records from 74 filers. 0 of the 74 filers that marked the item voted against management.

    • Positions of 27 fund families
    • For 27
  6. Item 6: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    14 vote records from 11 filers. 0 of the 11 filers that marked the item voted against management.

    • Positions of 3 fund families
    • For 3

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Kiniksa Pharmaceuticals International, plc, meeting of 29 May 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinForFor
AllspringForFor
American CenturyAgainst, against managementFor
BairdForNo report
BlackRock and iSharesForFor
BNY MellonForFor
Charles SchwabForFor
Columbia ThreadneedleForNo report
DimensionalForFor
DWSForFor
EquitableForFor
FidelityForFor
First TrustForFor
Franklin TempletonForNo report
Goldman SachsForFor
Harbor FundsForFor
InvescoAgainst, against managementFor
Jackson National fundsForFor
Janus HendersonForNo report
John Hancock and ManulifeForFor
Lincoln FinancialForFor
MFSForFor
Morgan Stanley, Eaton Vance and CalvertForFor
NationwideAgainst, against managementFor
Natixis and Loomis SaylesForNo report
Northern Trust and FlexSharesForFor
PGIM and PrudentialForFor
ProShares and ProFundsForFor
Russell InvestmentsForNo report
SEIForFor
State Street and SPDRForFor
VanguardForFor
Victory CapitalForFor
VirtusForFor
VoyaForFor
WisdomTreeForFor

Questions

How many filers reported votes at the Kiniksa Pharmaceuticals International, plc meeting?
303 Form N-PX filers reported votes at the meeting of 29 May 2026. On say-on-pay, 21 of 287 filers that marked the item voted against management (7.3%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Kiniksa Pharmaceuticals International, plc reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Kiniksa Pharmaceuticals International, plc with a meeting date within three days of 29 May 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .